Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy

S Binder, G Deuschl, J Volkmann - European neurology, 2009 - karger.com
Background: Tremor is one of the cardinal symptoms in Parkinson's disease, but only few
clinical studies have focussed on its therapy as the primary endpoint. One reason is the …
被引用次数：20 相关文章

Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy

S Binder, G Deuschl, J Volkmann - European neurology, 2009 - pubmed.ncbi.nlm.nih.gov
Background Tremor is one of the cardinal symptoms in Parkinson's disease, but only few
clinical studies have focussed on its therapy as the primary endpoint. One reason is the …

Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy.

S Binder, G Deuschl, J Volkmann - European Neurology, 2008 - europepmc.org
Background Tremor is one of the cardinal symptoms in Parkinson's disease, but only few
clinical studies have focussed on its therapy as the primary endpoint. One reason is the …

Effect of Cabergoline on Parkinsonian Tremor Assessed by Long-Term Actigraphy

S Binder, G Deuschl, J Volkmann - European Neurology, 2009 - search.proquest.com
Tremor is one of the cardinal symptoms in Parkinson's disease, but only few clinical studies
have focussed on its therapy as the primary endpoint. One reason is the substantial …

Effect of Cabergoline on Parkinsonian Tremor Assessed by Long-Term Actigraphy.

S Binder, G Deuschl, J Volkmann - European Neurology, 2009 - search.ebscohost.com
Background: Tremor is one of the cardinal symptoms in Parkinson's disease, but only few
clinical studies have focussed on its therapy as the primary endpoint. One reason is the …

Effect of Cabergoline on Parkinsonian Tremor Assessed by Long-Term Actigraphy

S Binder, G Deuschl, J Volkmann - European Neurology, 2009 - karger.com
Background: Tremor is one of the cardinal symptoms in Parkinson's disease, but only few
clinical studies have focussed on its therapy as the primary endpoint. One reason is the …